These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1848338)

  • 21. Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalin.
    Heyman JS; Vaught JL; Mosberg HI; Haaseth RC; Porreca F
    Eur J Pharmacol; 1989 Jun; 165(1):1-10. PubMed ID: 2548877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discriminative stimulus effects of a centrally administered, delta-opioid peptide (D-Pen2-D-Pen5-enkephalin) in pigeons.
    Jewett DC; Mosberg HI; Woods JH
    Psychopharmacology (Berl); 1996 Oct; 127(3):225-30. PubMed ID: 8912400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of 3H-D-Pen2-D-Pen5-enkephalin to brain regions and spinal cord membranes of spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Bhargava HN; Rahmani NH
    Pharmacology; 1993; 46(2):75-81. PubMed ID: 8382821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats.
    Sbacchi M; La Regina A; Petrillo P; Tavani A
    NIDA Res Monogr; 1986; 75():520-3. PubMed ID: 2828999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid modulation of basal intestinal fluid transport in the mouse: actions at central, but not intestinal, sites.
    Jiang Q; Sheldon RJ; Porreca F
    J Pharmacol Exp Ther; 1990 May; 253(2):784-90. PubMed ID: 2160010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes.
    Shippenberg TS; Bals-Kubik R; Herz A
    Brain Res; 1987 Dec; 436(2):234-9. PubMed ID: 2829990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists.
    Heyman JS; Jiang Q; Rothman RB; Mosberg HI; Porreca F
    Eur J Pharmacol; 1989 Oct; 169(1):43-52. PubMed ID: 2557223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
    Mattia A; Farmer SC; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Bowen WD; Porreca F
    J Pharmacol Exp Ther; 1992 Feb; 260(2):518-25. PubMed ID: 1310737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective delta agonist in vivo.
    Qi JA; Mosberg HI; Porreca F
    Life Sci; 1990; 47(11):PL43-7. PubMed ID: 2170791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.
    Paul D; Bodnar RJ; Gistrak MA; Pasternak GW
    Eur J Pharmacol; 1989 Sep; 168(3):307-14. PubMed ID: 2555205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.
    Mattia A; Vanderah T; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1991 Aug; 258(2):583-7. PubMed ID: 1650835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo studies on delta opioid receptors.
    Cowan A; Rance MJ; Blackburn TP
    NIDA Res Monogr; 1986; 75():473-6. PubMed ID: 2828995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of [3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma--glioma hybrid cell line (NG 108-15).
    Akiyama K; Gee KW; Mosberg HI; Hruby VJ; Yamamura HI
    Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2543-7. PubMed ID: 2986120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of antagonism of the NMDA receptor on tolerance to [D-Pen2,D-Pen5]enkephalin, a delta 1-opioid receptor agonist.
    Zhao GM; Bhargava HN
    Peptides; 1996; 17(2):233-36. PubMed ID: 8801526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ventral pallidal microinjections of receptor-selective opioid agonists produce differential effects on circling and locomotor activity in rats.
    Hoffman DC; West TE; Wise RA
    Brain Res; 1991 Jun; 550(2):205-12. PubMed ID: 1653084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mu and delta opioid receptors inhibit serotonin release in rat hippocampus.
    Passarelli F; Costa T
    J Pharmacol Exp Ther; 1989 Jan; 248(1):299-305. PubMed ID: 2536429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between highly selective mu and delta opioids in vivo at the rat spinal cord.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    NIDA Res Monogr; 1986; 75():97-100. PubMed ID: 2829017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole body and brain distribution of [3H]cyclic [D-Pen2,D-Pen5] enkephalin after intraperitoneal, intravenous, oral and subcutaneous administration.
    Weber SJ; Greene DL; Hruby VJ; Yamamura HI; Porreca F; Davis TP
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1308-16. PubMed ID: 1469637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.